Publications

Allain, P., Gaura, V., Fasotti, L., Chauviré, V., Prundean, A., Sherer-Gagou, C., Bonneau, D., Bachoud-Levi, A., Dubas, F., Remy, P., Le Gall, D. & Verny, C. (2011). The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease. Neuropsychologia, 49(9), 2673-84. doi:10.1016/j.neuropsychologia.2011.05.015

Shin, M., Jan, C., Jacquard, C., Jarraya, B., Callebert, J., Launay, J., Hantraye, P., Remy, P., Palfi, S. & Brouillet, E. (2011). Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of aging, 32(11), 2100-2. doi:10.1016/j.neurobiolaging.2009.11.015

Dulin, D., Cavezian, C., Serrière, C., Bachoud-Levi, A., Bartolomeo, P. & Chokron, S. (2011). Colour, face, and visuospatial imagery abilities in low-vision individuals with visual field deficits. Quarterly journal of experimental psychology (2006), 64(10), 1955-70. doi:10.1080/17470218.2011.608852

Freeman, T., Cicchetti, F., Bachoud-Levi, A. & Dunnett, S. (2011). Technical factors that influence neural transplant safety in Huntington's disease. Experimental Neurology, 227(1), 1-9. doi:10.1016/j.expneurol.2010.08.031

Fenelon, G., Soulas, T., Cleret de Langavant, L., Trinkler, I. & Bachoud-Levi, A. (2011). Feeling of presence in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 82(11), 1219-24. doi:10.1136/jnnp.2010.234799

Passeri, E., Villa, C., Couette, M., Itti, E., Brugières, P., Cesaro, P., Gherardi, R., Bachoud-Levi, A. & Authier, F. (2011). Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). Journal of inorganic biochemistry, 105(11), 1457-63. doi:10.1016/j.jinorgbio.2011.08.006

Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E., Sassone, J., Ciammola, A., Bachoud-Levi, A., Tabrizi, S., Di Donato, S. & Cattaneo, E. (2011). Brain-derived neurotrophic factor in patients with Huntington's disease. PloS one, 6(8), e22966. doi:10.1371/journal.pone.0022966

Vaccarino, A., Sills, T., Anderson, K., Bachoud-Levi, A., Borowsky, B., Craufurd, D., Duff, K., Giuliano, J., Groves, M., Guttman, M., Kupchak, P., Ho, A., Paulsen, J., Pedersen, K., Van Duijn, E., Van Kammen, D. & Evans, K. (2011). Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS currents, 3, RRN1242. doi:10.1371/currents.RRN1242

Robotham, L., Sauter, D., Bachoud-Levi, A. & Trinkler, I. (2011). The impairment of emotion recognition in Huntington's disease extends to positive emotions. Cortex; a journal devoted to the study of the nervous system and behavior, 47(7), 880-4. doi:10.1016/j.cortex.2011.02.014

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Jacquemot, C., Dupoux, E., Robotham, L. & Bachoud-Levi, A. (2012). Specificity in rehabilitation of word production: a meta-analysis and a case study. Behavioural Neurology, 25(2), 73-101

Lavisse, S., Guillermier, M., Hérard, A., Petit, F., Delahaye, M., Van Camp, N., Ben Haim, L., Lebon, V., Remy, P., Dollé, F., Delzescaux, T., Bonvento, G., Hantraye, P. & Escartin, C. (2012). Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. The Journal of neuroscience : the official journal of the Society for Neuroscience, 32(32), 10809-18. doi:10.1523/JNEUROSCI.1487-12.2012

Chaumeil, M., Valette, J., Baligand, C., Brouillet, E., Hantraye, P., Bloch, G., Gaura, V., Rialland, A., Krystkowiak, P., Verny, C., Damier, P., Remy, P., Bachoud-Levi, A., Carlier, P. & Lebon, V. (2012). pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 32(5), 771-9. doi:10.1038/jcbfm.2012.15

Rosser, A. & Bachoud-Levi, A. (2012). Clinical trials of neural transplantation in Huntington's disease. Progress in brain research, 200, 345-71. doi:10.1016/B978-0-444-59575-1.00016-8

Sambin, S., Teichmann, M., De Diego Balaguer, R., Giavazzi, M., Sportiche, D., Schlenker, P. & Bachoud-Levi, A. (2012). The role of the striatum in sentence processing: disentangling syntax from working memory in Huntington's disease. Neuropsychologia, 50(11), 2625-35. doi:10.1016/j.neuropsychologia.2012.07.014

Charlotte, J. & Emmanuel, D. (2013). The second person in “I”-“you”-“it” triadic interactions. Behavioral and Brain Sciences, 36(04), 416--417. doi:10.1017/s0140525x12001860

The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E. & Registry Investigators Of The European Huntington'S Disease, N. (2013). β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease. Journal of Huntington's disease. doi:10.3233/jhd-130002

Cleret de Langavant, L., Fenelon, G., Benisty, S., Boissé, M., Jacquemot, C. & Bachoud-Levi, A. (2013). Awareness of memory deficits in early stage Huntington's disease. PloS one, 8(4), e61676. doi:10.1371/journal.pone.0061676

Cleret de Langavant, L., Jacquemot, C., Bachoud-Levi, A. & Dupoux, E. (2013). The second person in "I"-"you"-"it" triadic interactions. The Behavioral and brain sciences, 36(4), 416-7. doi:10.1017/S0140525X12001860

Jacquemot, C. (2013). Y’a t-il un centre du langage ? Sciences Humaines, Mars, 56-57.

Trinkler, I., Cleret de Langavant, L. & Bachoud-Levi, A. (2013). Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings. Cortex; a journal devoted to the study of the nervous system and behavior, 49(2), 549-58. doi:10.1016/j.cortex.2011.12.003

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., Scherer, C., Tranchant, C., Goizet, C., Debruxelles, S., Defebvre, L., Sablonnière, B., Romon-Rousseaux, M., Buée, L., Destée, A., Godefroy, O., Durr, A., Landwehrmeyer, B., Registry Study Of The European Huntington'S Disease, N., Bachoud-Levi, A., Richard, F., Blum, D., Krystkowiak, P. & Huntington French Speaking, N. (2013). Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of disease, 58, 179-82. doi:10.1016/j.nbd.2013.05.013

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E., Bachoud-Levi, A. & Registry Investigators Of The European Huntington’s Disease, N. (2013). β-defensin genomic copy number does not influence the age of onset in huntington’s disease. Journal of Huntington's Disease, 2(1), 107-124. doi:10.3233/JHD-130047

Hubers, A., Duijn, E., Roos, R., Craufurd, D., Rickards, H., Landwehrmeyer, G., Van Der Mast, R., Giltay, E., Bachoud-Levi, A., Registry Investigators Of The European Huntington’s Disease, N. & Quarrell, O. (2013). Suicidal ideation in a European Huntington's disease population. Journal of Affective Disorders, 151(1), 248-258. doi:10.1016/j.jad.2013.06.001

Youssov, K., Dolbeau, G., Maison, P., Boissé, M., Cleret de Langavant, L., Roos, R. & Bachoud-Levi, A. (2013). The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study. Movement disorders : official journal of the Movement Disorder Society, 28(14), 1995-2001. doi:10.1002/mds.25678

Levi Marpillat, N., Macquin-Mavier, I., Tropeano, A., Bachoud-Levi, A. & Maison, P. (2013). Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. Journal of hypertension, 31(6), 1073-82. doi:10.1097/HJH.0b013e3283603f53

Désaméricq, G., Dolbeau, G., Verny, C., Charles, P., Durr, A., Youssov, K., Simonin, C., Azulay, J., Tranchant, C., Goizet, C., Damier, P., Broussolle, E., Démonet, J., Morgado, G., Cleret de Langavant, L., Macquin-Mavier, I., Bachoud-Levi, A. & Maison, P. (2014). Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort. PloS one, 9(1), e85430. doi:10.1371/journal.pone.0085430

Palfi, S., Gurruchaga, J., Ralph, G., Lepetit, H., Lavisse, S., Buttery, P., Watts, C., Miskin, J., Kelleher, M., Deeley, S., Iwamuro, H., Lefaucheur, J., Thiriez, C., Fenelon, G., Lucas, C., Brugières, P., Gabriel, I., Abhay, K., Drouot, X., Tani, N., Kas, A., Ghaleh, B., Le Corvoisier, P., Dolphin, P., Breen, D., Mason, S., Guzman, N., Mazarakis, N., Radcliffe, P., Harrop, R., Kingsman, S., Rascol, O., Naylor, S., Barker, R., Hantraye, P., Remy, P., Cesaro, P. & Mitrophanous, K. (2014). Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet (London, England), 383(9923), 1138-46. doi:10.1016/S0140-6736(13)61939-X

Bartolomeo, P., Bachoud-Levi, A. & De Schotten, T. (2014). The anatomy of cerebral achromatopsia: a reappraisal and comparison of two case reports. Cortex, 56, 138-44. doi:10.1016/j.cortex.2013.01.013